Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1551 studies found for:    Open Studies | mri
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | mri
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting 3T MRI Biomarkers of Glioma Treatment Response
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Device: 3-Tesla magnetic resonance imaging;   Device: CEST-MRI;   Device: DW-MRI;   Device: DCE-MRI;   Device: DSC-MRI;   Drug: IV administration of gadolinium-containing contrast agent
2 Recruiting Safety and Efficacy of St Jude Medical ( SJM ) MRI Conditional Pacing System Undergoing Cardiac MRI Scan
Condition: Bradycardia
Interventions: Procedure: Cardiac MRI scan;   Device: SJM MRI conditional pacing system implant
3 Recruiting 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: 3-Tesla magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging
4 Recruiting Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: high field strength magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Procedure: chemical exchange saturation transfer magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
5 Not yet recruiting Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Conditions: Glioma;   Pilocytic Astrocytoma;   Anaplastic Astrocytoma;   Glioblastoma;   Mixed Oligoastrocytoma;   Mixed Glioma;   Oligodendroglioma;   Optic Glioma;   Astrocytoma
Interventions: Procedure: MRI-guided laser ablation;   Drug: Doxorubicin;   Drug: Etoposide;   Device: Dynamic contrast-enhanced (DCE) MRI;   Device: Dynamic susceptibility contrast (DSC) MRI
6 Not yet recruiting Quantitative MRI in Assessing Disease in Patients With Brain Metastases
Conditions: Tumors Metastatic to Brain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: chemical exchange saturation transfer magnetic resonance imaging;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: dynamic susceptibility contrast-enhanced magnetic resonance imaging
7 Recruiting Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI
Condition: Head and Neck Cancer
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Drug: Ferumoxytol
8 Recruiting T2 Weighted Imaging of the Liver With Fast Spin Echo MRI
Condition: Liver Disease
Intervention: Device: MRI examinations
9 Not yet recruiting FAST MRI Study in Breast Cancer Survivors
Condition: Breast Cancer
Intervention: Other: FAST MRI and mammography screening
10 Recruiting Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina
Condition: Vaginal Cancer
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Diffusion Weighted Magnetic Resonance Imaging (DWMR)
11 Recruiting Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer
Condition: Recurrent Prostate Cancer
Interventions: Procedure: computed tomography;   Procedure: bone scan;   Procedure: 3-Tesla magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Radiation: fluorine F 18 sodium fluoride;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis
12 Recruiting MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Cancer;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography
13 Recruiting Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
Condition: Adult Brain Glioblastoma
Interventions: Drug: gadoteridol;   Drug: Ferumoxytol Non-Stoichiometric Magnetite;   Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging;   Procedure: Magnetic Resonance Imaging
14 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
15 Recruiting PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Conditions: Recurrent Colon Cancer;   Recurrent Rectal Cancer;   Stage IIA Colon Cancer;   Stage IIA Rectal Cancer;   Stage IIB Colon Cancer;   Stage IIB Rectal Cancer;   Stage IIC Colon Cancer;   Stage IIC Rectal Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Rectal Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer
Interventions: Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging;   Radiation: fludeoxyglucose F 18
16 Recruiting 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC)
Interventions: Device: 3 Tesla Magnetic Resonance Imaging;   Drug: Magnevist® (Intravenous (IV) administration of MRI contrast agent)
17 Recruiting FLT-PET/MRI in Measuring Early Response in Patients With Metastatic Solid Tumors Receiving Treatment That Blocks Blood Flow to the Tumor
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Other: fluorine F 18 fluorothymidine;   Procedure: positron emission tomography;   Procedure: magnetic resonance imaging
18 Recruiting PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer
Condition: Childhood Cancer
Interventions: Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
19 Recruiting 18F FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly Diagnosed or Recurrent Gliomas
Conditions: Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Diffuse Astrocytoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Recurrent Adult Brain Tumor;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Cerebellar Astrocytoma;   Untreated Childhood Cerebral Astrocytoma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Visual Pathway and Hypothalamic Glioma;   Untreated Childhood Visual Pathway Glioma
Interventions: Drug: fluorine F 18 fluorodopa;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
20 Recruiting Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Conditions: Hepatocellular Carcinoma;   HCC
Intervention: Device: Magnetic Resonance Imaging

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years